Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
gjFe4W1hJB3Ds4gr
